The 0.80x price-to-book sits below Dorman (2.70), Standard Motor Products (1.22) and Strattec (1.06), but investors should weigh that gap against MPAA's $32.1M equity contraction over ten quarters, since a shrinking book base mechanically lowers the ratio even as it signals capital decay. The step-down from a 17.18 trailing to a 14.20 forward P/E implies analysts are modeling a recovery from 2027Q1's -8.0% net margin, an assumption that appears contingent on gross margin returning toward the 23-24% seen in 2026Q4 and 2025Q3. The 8.82 P/FCF multiple warrants particular caution, as trailing four-quarter free cash flow is roughly negative $4M, leaving the multiple anchored to a cash generation profile that has already inflected.

ROIC has oscillated between -0.9% and 3.8% without discernible trend, and the driver appears to be margin rather than asset efficiency: operating margin swung from -3.8% to 10.6% across the period while asset turnover remained pinned between 0.17 and 0.23. Against Dorman's 13.9%, SMP's 10.6% and Strattec's 8.7% ROIC, MPAA's spread looks structural rather than cyclical, which may indicate the aftermarket program structure and cost base leave less economic rent per dollar invested. ROE of -5.2% in 2027Q1, read alongside an equity base that has fallen to $253.0M, suggests the company is currently decaying rather than compounding returns on shareholder capital.

Because DSO has held in a relatively tight 48-68 day band throughout the ten quarters, the cycle's expansion from a 146-day low in 2026Q2 appears almost entirely inventory-driven, consistent with the $59.7M of working capital absorbed over the three quarters ending 2027Q1. Asset turnover of 0.17, its joint-lowest reading versus a 0.23 peak, implies each dollar of assets is converting into less revenue, which would mechanically pressure ROIC even if margins held. For a manufacturer carrying 262 days of stock, investors should monitor whether the build reflects deliberate program stocking against the $304.5M deferred revenue backlog or slower-moving replacement-parts demand, as the two readings carry very different cash flow implications.

The debt-to-equity ratio of 0.90 is its highest since 2025Q1 and has risen as equity fell to $253.0M, so part of the leverage increase appears to come from the denominator rather than new borrowing, a distinction that matters for refinancing conversations. The 114.81x D/EBITDA reading should be treated as distorted by a depressed EBITDA quarter rather than a literal solvency measure, but the coverage collapse from 2.17x to 0.17x is the more interpretable signal that debt service comfort has deteriorated sharply. With $19.1M of cash against $228.7M of total debt, and $304.5M of deferred revenue sitting as a non-debt claim ahead of equity, covenant headroom and refinancing terms warrant close monitoring.